Skip to main content

Table 7 Total number of serious adverse events (SAEs), and number of patients with at least one SAE groups in each analysis set (intention-to-treat or per protocol)

From: Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke

Types of events

Group 0

Group 1

Events, N

Patients with at least one event, N

Patients assessed, N

Events, N

Patients with at least one event, N

Patients assessed, N

Any event

      

Event type 1

      

Event type 2

      

Event type 3

      

Etc